SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Robinhood Markets, Inc is a financial services platform, which engages in the provision of retail brokerage and offers trading in U.S. listed stocks and Exchange Traded Funds, related options, and cryptocurrency trading, as well as cash management, which includes debit cards services. The company was founded by Vladimir Tenev and Baiju Prafulkumar Bhatt in 2013 and is headquartered in Menlo Park, CA.

Robinhood Markets Inc - Ordinary Shares - Class A

Robinhood Markets Inc

Robinhood is trending due to its anticipated inclusion in the S&P 500, sparking excitement among investors who foresee potential institutional investment and a price surge akin to Palantir's after its inclusion. The community is actively discussing potential short squeezes, target prices, and the impact of the upcoming company summit and potential Federal Reserve rate cuts on the stock's performance. Some investors are cautioning against excessive optimism, citing previous instances where stocks experienced declines post-inclusion.

Schwab Strategic Trust - Schwab US Dividend Equity ETF

Schwab US Dividend Equity ETF

SCHD is trending as investors weigh its dividend yield against recent market performance, with some expressing frustration over underperformance compared to growth-focused ETFs. The community is actively debating whether to hold SCHD for long-term income or rotate into higher-growth opportunities, especially as some point to its heavy weighting in energy and healthcare sectors. Recent discussions also highlight anticipation for the next dividend announcement and how broader economic factors like interest rate cuts and potential tariffs might impact the ETF.

Pineapple Financial, Inc. is a Canadian based mortgage technology and brokerage company, which engages in the mortgage brokerage services and technology solutions to Canadian mortgage agents, brokers, sub-brokers, brokerages, and consumers. The company also provides back-office services, together with pre-underwriting support services. The company was founded by Shubha Dasgupta, Kendall Marin, and Charles Andrew Green on October 16, 2015 and is headquartered in North York, Canada.

Pineapple Financial Inc

Pineapple Financial ($PAPL) is trending due to its recent $100 million private placement and strategic move into Injective ($INJ.X) digital assets. The community is actively discussing potential short squeezes and the stock's volatile price action, while also debating the long-term prospects of PAPL given its financial situation. Some traders are wary of dilution, while others see significant upside potential due to the small float and high borrowing costs.

Gyrodyne LLC engages in the management of a portfolio of medical office and industrial properties. Its properties include Flowerfield, Port Jefferson Professional Park, Courtland Medical Center, and Grove. The company was founded by Peter James Papadakos in 1946 and is headquartered in St. James, NY.

Gyrodyne LLC

GYRO is trending due to increased attention on its low float and potential for a significant breakout, with some traders drawing comparisons to other low-float runners. Community members are closely watching key breakout levels, speculating about a potential meme run and a possible short squeeze. Some investors believe the company is undervalued considering recent property sales.

Infinite Money Glitch ($IMG) is revolutionizing DeFi on Solana by leveraging the Token2022 program's advanced tax extension capabilities to create a truly innovative reward system for token holders.  At its core, $IMG implements a seamless 5% tax on all transactions - whether buying, selling, or transferring tokens. This tax is automatically collected and distributed to holders in SOL, creating a sustainable passive income stream for the community. 4.5% of the tax gets sent to holders, while .5% gets sent to an Infrastructure wallet to help with development, marketing and general infrastructure.  What sets $IMG apart is its implementation of Solana's Token2022 program, enabling automated and efficient reward distribution without relying on external smart contracts.

Infinite Money Glitch

Infinite Money Glitch ($IMG.X) is trending as the community rallies around its Solana ($SOL.X) reward system for holders, emphasizing passive income and a strong community. The token's resilience and recent sponsorship with Kimbo Slice Jr. are also key talking points, with members highlighting the project's longevity and unique reward structure within the crypto space.

Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.

Ocular Therapeutix Inc

Ocular Therapeutix is trending as chatter revolves around potential acquisition bids and analyst optimism for their drug candidate, AXPAXLI, despite recent market volatility. Community members speculate on buyout prices and partnerships, focusing on the upcoming SOL-1 data and its potential impact on valuation. Some traders are weighing OCUL against competitors in the wet AMD space, while others discuss the broader biotech sector trends.

Aventus

Aventus is trending, with community members highlighting a new partnership with The Truth Network. Bullish sentiment seems to be building with anticipation of a potential listing on a top 10 exchange. Some traders are pointing to the token's low market cap and limited supply as factors that could drive price appreciation.

Procter & Gamble Co. engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances. The Health Care segment includes oral care products like toothbrushes, toothpaste, and personal health care such as gastrointestinal, rapid diagnostics, respiratory, and vitamins, minerals, and supplements. The Fabric and Home care segment consists of fabric enhancers, laundry additives and detergents, and air, dish, and surface care. The Baby, Feminine and Family Care segment sells baby wipes, diapers, and pants, adult incontinence, feminine care, paper towels, tissues, and toilet paper. The company was founded by William Procter and James Gamble in 1837 and is headquartered in Cincinnati, OH.

Procter & Gamble Co.

Procter & Gamble is trending as traders discuss its potential upside and key resistance levels, with some eyeing it as a safe haven amid market uncertainty. Community members are actively considering options strategies and anticipating a run toward specific price targets, while also monitoring news related to analyst ratings and potential tariff impacts. Broader discussions involve P&G's role as a defensive stock and its established history of dividend increases.

aTyr Pharma, Inc. engages in the discovery and development of medicines based on novel biological pathways. Its product pipeline includes ATYR1923, ATYR2810, NRP2 mAbs, and AARS-1, DARS-1. The company was founded by Paul Schimmel, Xiang-Lei Yang and Bruce Beutler on September 8, 2005 and is headquartered in San Diego, CA.

Atyr Pharma Inc

aTyr Pharma, Inc

Shares of ATYR are active amid ongoing discussions about upcoming data from a Phase 3 trial, with some speculating on a potential catalyst date while others assess the likelihood of success. Bullish sentiment is fueled by employee stock options and new hires, interpreted as confidence in positive results, although some traders are hedging their bets. The community is debating the company's financial moves and the potential impact of positive data on its long-term prospects.

Beam Therapeutics, Inc. is a biotechnology company, which engages in the establishment of integrated platform for precision genetic medicines. Its pipeline includes BEAM-101, BEAM-302, Engineered Stem Cell Antibody Paired Evasion (ESCAPE), BEAM-301, and BEAM-201. The company was founded by David R. Liu, Feng Zhang, Alexis Komor, Nicole Gaudelli, and J. Keith Joung on January 25, 2017 and is headquartered in Cambridge, MA.

Beam Therapeutics Inc

BEAM is trending as investors anticipate catalysts related to a September 14th date mentioned frequently across social media, though the specific event is unconfirmed, creating speculation and driving interest. Recent #BeamTherapeutics mentions include discussion around new data, comparisons to Wave Life Sciences ($WVE), and analysts highlighting Beam's base-editing advantages within the broader gene editing space, particularly for AATD.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Morgan Stanley initiated coverage on Duolingo (DUOL) with an 'Overweight' rating and $435 price target on the company's shares, The Fly reported.The vote of confidence from one of Wall Street’s biggest firms sent Duolingo shares up 10% to $370 on Wednesday. With 6.4% gains the previous day, it is the stock's best two-day run since August 2024."We see DUOL as a best-in-class consumer internet asset," Morgan Stanley analysts said in an investor note.They said the language learning app has the "rare combination" of rapid user growth, strong and expanding margins, and a clear generative artificial intelligence upside.The company also has a vast scope for monetization, they said, as it does not run ads, and the current monetization on the platform is about five times below mobile peers.Morgan Stanley also believes Duolingo's market of language learners is far from saturated."With each growth vector magnifying the others we see DUOL as a structural compounder and model a 26% 5-year revenue CAGR," it said.Earlier this month, JPMorgan reiterated Duolingo as its "Best Idea" in the online education sector, citing its strong prospects for user growth and monetization.&nbsp;&nbsp;In other corporate news, Duolingo said this week that it is adding a chess course, which includes the ability to play matches against an AI coach.On Stocktwits, retail sentiment turned to 'extremely bullish' from 'bearish' a day prior, and message volume 'high'.<figure class="image"><img style="aspect-ratio:811/180;" src="https://news.stocktwits-cdn.com/Screenshot_2025_04_24_at_8_58_08_AM_png_59cf966d29.webp" alt="Screenshot 2025-04-24 at 8.58.08 AM.png" width="811" height="180"><figcaption>DUOL sentiment and message volume as of April 23 | Source: Stocktwits</figcaption></figure>Several users posted comments suggesting that the backing from Morgan Stanley was a strong buying signal.<stembedurl>https://stocktwits.com/IN0V8/message/612453196</stembedurl><a href="https://stocktwits.com/symbol/DUOL">Shares</a> of Duoling are up over 14% year to date.For updates and corrections, email newsroom[at]stocktwits[dot]com.

A laptop keyboard and Duolingo on App Store displayed on a phone screen are seen in this illustration photo. (Photo by Jakub Porzycki/NurPhoto via Getty Images)

Duolingo 'Best-In-Class' Internet Stock, Says Morgan Stanley With 'Buy' Call: Retail Sentiment Flips To Extremely Bullish

The investment bank said Duolingo has the rare combination of rapid user growth, strong and expanding margins, and a clear generative artificial intelligence upside.

Equity

The investment bank said Duolingo has the rare combination of rapid user growth, strong and expanding margins, and a clear generative artificial intelligence upside.


Shares of Celsius Holdings Inc. (CELH) soared nearly 36% in after-hours trading Thursday after the energy drinks maker reported a quarterly earnings beat and agreed to acquire Alani Nutrition LLC for $1.8 billion, lifting retail sentiment.The transaction, which includes a mix of cash and stock including a potential $25 million earn-out, will combine “two growing, scaled brands in the U.S. energy drink category,” Celsius said in a statement. The transaction is expected to close in the second quarter of 2025.Founded in 2018, Alani Nu is a growing, female-focused brand that combined with Celsius, is expected to drive about $2 billion in sales.Separately, Celsius Holdings also reported better-than-expected earnings for its fourth quarter."Our record $1.36 billion full-year 2024 revenue reflects a solid year of performance, underscored by consumers' continued preference for our great-tasting, functional products. Celsius achieved exceptional milestones in 2024, which included contributing 30% of all category growth and increasing our category share by 160 basis points to 11.8%,” said John Fieldly, chairman and CEO of Celsius Holdings.Celsius’s Q4 adjusted earnings per share came in at $0.14, surpassing consensus estimates of $0.10, while Q4 revenue stood at $332.2 million, beating expectations of $326.19 million.Sentiment on Stocktwits inched up in the ‘extremely bullish’ zone with commenters cheering the earnings and the deal. Message volumes jumped to the ‘extremely high’ zone.<img src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2025_02_21_at_7_25_06_AM_79eee9c0c2.png" alt="Screenshot 2025-02-21 at 7.25.06 AM.png">One bullish commenter expects Celsius stock to reach $70 on Friday.<stembedurl>https://stocktwits.com/Baskinta1/message/605098008</stembedurl>The acquisition of Alani Nu will further strengthen Celsius' position in the “large, growing global energy category” which is projected to grow at a compounded annual growth rate of 10% from 2024 to 2029, the company noted.It is expected to boost cash EPS in the first year, with projected run-rate cost synergies of $50 million within two years.Retail sales of Alani Nu increased by 78% year-over-year as reported by Circana for the last-four-week period ended Jan. 26, 2025, the company noted. &nbsp;The purchase price for Alani Nu consists of $1.27 billion of cash and a $25 million earn-out and $500 million of newly issued restricted shares of Celsius Holdings common stock, representing about 8.7% pro-forma ownership.The cash payment consists of debt financing of $900 million and about $375 million of cash on hand, according to Celsius.Celsius stock is down 3% year-to-date.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Celsius Holdings Stock Soars On $1.8B Alani Nu Acquisition, Q4 Earnings Beat: Retail’s Exuberant

Sentiment on Stocktwits inched up in the ‘extremely bullish’ zone.

Shares of Celsius Holdings (CELH) slipped more than 5% on Wednesday after brokerage firm TD Cowen downgraded its stock to ‘hold’ from ‘buy,’ dampening retail sentiment.TD Cowen also cut its price target to $29 from $40, Fly.com reported. According to the report, TD Cowen’s retail tracking data showed a decline in the company's sales growth to 0.3% in the last four weeks ending January 11.With Celsius shares well below its highs, valuation multiples could contract further if the company goes "ex-growth," said the report, citing the analyst who warned against heightened competition.Morgan Stanley also highlighted NielsenIQ data that showed Celsius' year-over-year sales dipped in the last two weeks that were assessed, showing a 6% decline in the latest week.Morgan Stanley has kept its ‘Equal Weight’ rating and $42 price target.Sentiment on Stocktwits turned ‘bearish’ from ‘bullish’ a week ago. Message volumes rose to ‘extremely high’ levels from ‘normal.’<img src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2025_01_23_at_10_23_38_AM_d72c2aed5e.png" alt="Screenshot 2025-01-23 at 10.23.38 AM.png"> Last week, UBS analyst Peter Grom also cut the firm's price target to $39 from $45 with a ‘Buy’ rating, Fly.com reported. According to the analyst, sentiment about consumer staples continues to be bearish despite the sector underperformance compared to the broader market in recent years, with top and bottom line growth for majority of the group has underwhelmed compared to expectations.Celsius is a maker of premium lifestyle energy drinks under its namesake 'Celsisus' brand.Celsius stock is down 3.7% year-to-date.For updates and corrections, email newsroom[at]stocktwits[dot]com.

(Photo by John Parra/Getty Images for CELSIUS)

Celsius Stock Slips On Analyst Downgrade Amid Rising Competition: Retail Mood Dampens

Sentiment on Stocktwits turned ‘bearish’ from ‘bullish’ a week ago. 

XJH
iShares ESG Screened S&P Mid-Cap ETF

Feed

News

Sentiment

Fundamentals

Info

Latest XJH News

XJH iShares ESG Screened S&P Mid-Cap ETF